IP Licensing

Licensing executives and IP management experts advise on licensing patent portfolios, valuation and technology transfer.

Alnylam and Isis cross-license

New agreement includes cross-license on four disease targets, providing each company exclusive RNA therapeutic license rights for two programs

January 12, 2015

1 2 3 54